市场调查报告书
商品编码
1305942
软胶囊市场 - 按类型(明胶胶囊、素食胶囊)、按应用(处方药、保健品和膳食补充剂)、按生产商(制药、保健品),全球预测2023 - 2032年Softgel Capsules Market - By Type (Gelatin Based, Vegetarian Capsules), By Application (Prescription Medicines, Health & Dietary Supplements), By Manufacturer (Pharmaceutical, Nutraceutical), Global Forecast 2023 - 2032 |
到2032年,全球软胶囊市场规模将急剧扩大。快速增长的老年人口及其对慢性疾病的易感性增加了对软胶囊的需求。据世界卫生组织预测,到2040年,中国60岁以上人口将达到4.02亿。此外,发达经济体和发展中经济体蓬勃发展的医疗保健基础设施将进一步为行业增长创造大量机会。同样,2022年10月,美国农业部宣布投资约1.1亿美元改善农村人口的医疗保健。
整个软胶囊市场根据类型、应用、制造商和地区进行划分。
就类型而言,素食胶囊市场价值将在2022-2032年期间实现可观增长。素食胶囊制造技术的不断创新将促进该细分市场的增长。制造商正在探索素食胶囊的定制和组合能力。这包括开发多腔或多层胶囊,允许在单粒胶囊中加入不同的成分或配方。这种定制可实现精确给药、联合治疗,并为患者提供更多便利。
在应用方面,2022年健康和膳食补充剂细分市场的行业规模达到58.5亿美元。人们健康意识的提高增加了膳食补充剂的消费量。根据国际贸易管理局的数据,日本膳食补充剂行业价值94亿美元,是全球第三大膳食补充剂行业。此外,全球各地政府为使这些补充剂价格合理而做出的努力也进一步促进了该细分市场的增长。
从生产商来看,制药公司的行业价值将在2032年之前大幅增长。全球各地政府为扩大制药行业而增加的投资对该细分市场的前景产生了积极影响。2023年3月,英国政府宣布向四家生命科学公司提供约2.77亿英镑(约3.01亿美元)的政府和私人投资。此外,制药公司大量供应各种软胶囊将进一步促进该细分市场的增长。
从区域角度来看,2022年欧洲软胶囊的市场份额超过33%。消费者对植物来源产品的支出增加,提高了该地区对素食软胶囊的需求。此外,可支配收入的增加推动了消费者在营养保健品和膳食补充剂方面的支出,提高了产品的吸收率。该地区的增长还得益于蓬勃发展的医疗保健基础设施和领先行业巨头的强大影响力。
Global Softgel Capsules Market size will expand exponentially through 2032. Rapidly increasing geriatric population and its susceptibility to chronic disorders has increased the demand for softgel capsules. As per WHO, in China, the population of people above 60 years will reach 402 million by 2040. Moreover, the flourishing healthcare infrastructure in developed and developing economies will further create ample opportunities for industry growth. In the same direction, in October 2022, the USDA unveiled an investment of around USD 110 million to improve healthcare for rural people.
The overall softgel capsules market is divided based on type, application, manufacturer, and region.
Regarding the type, the vegetarian capsules market value will depict appreciable growth over 2022-2032. Growing innovations in the manufacturing technology of vegetarian capsules will contribute to segment growth. Manufacturers are exploring the customization and combination capabilities of vegetarian capsules. This involves the development of multi-chamber or multi-layer capsules that allow for the incorporation of different ingredients or formulations within a single capsule. This customization enables precise dosing, combination therapies, and improved patient convenience.
With respect to application, the industry size from the health & dietary supplements segment reached over USD 5.85 billion in 2022. Surging health consciousness among people has increased the consumption of dietary supplements. As per the International Trade Administration, Japan's dietary supplements industry, valued at USD 9.4 billion, is the third-largest dietary supplement industry in the world. Moreover, growing efforts by governments across the globe towards making these supplements affordable are further contributing to segment growth.
Based on the manufacturer, industry value from the pharmaceutical companies will amass significant gains through 2032. Rising investment by governments across the globe towards expanding the pharmaceutical sector is positively affecting segment outlook. In March 2023, the UK government announced a government and private investment of around £277 million (~USD 301 million) to four life science companies. Moreover, the high availability of a wide range of softgel capsules in pharmaceutical companies will further contribute to segment growth.
From a regional perspective, Europe softgel capsules market share was more than 33% in 2022. Rising consumer spending on plant-sourced products has increased the demand for vegan softgel capsules in the region. Moreover, surging disposable income has propelled consumer spending on nutraceuticals and dietary supplements, increasing product uptake. Regional growth can also be ascribed to the flourishing healthcare infrastructure and the strong presence of leading industry giants.